A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

Satish Keshav; Tomáš Vaňásek; Yaron Niv; Robert Petryka; Stephanie Howaldt; Mauro Bafutto; István Rácz; David Hetzel; Ole Haagen Nielsen; Séverine Vermeire; Walter Reinisch; Per Karlén; Stefan Schreiber; Thomas J Schall; Pirow Bekker

doi:10.1371/journal.pone.0060094

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

Satish Keshav, Tomáš Vaňásek, Yaron Niv, Robert Petryka, Stephanie Howaldt, Mauro Bafutto, István Rácz, David Hetzel, Ole Haagen Nielsen, Séverine Vermeire, Walter Reinisch, Per Karlén, Stefan Schreiber, Thomas J Schall, Pirow Bekker

IKM

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

132 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	e60094
Tidsskrift	P L o S One
Vol/bind	8
Udgave nummer	3
Antal sider	12
ISSN	1932-6203
DOI	https://doi.org/10.1371/journal.pone.0060094
Status	Udgivet - 2013

Adgang til dokumentet

10.1371/journal.pone.0060094

Citationsformater

Keshav, S., Vaňásek, T., Niv, Y., Petryka, R., Howaldt, S., Bafutto, M., Rácz, I., Hetzel, D., Nielsen, O. H., Vermeire, S., Reinisch, W., Karlén, P., Schreiber, S., Schall, T. J., & Bekker, P. (2013). A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease. P L o S One, 8(3), Artikel e60094. https://doi.org/10.1371/journal.pone.0060094

Keshav, S, Vaňásek, T, Niv, Y, Petryka, R, Howaldt, S, Bafutto, M, Rácz, I, Hetzel, D, Nielsen, OH, Vermeire, S, Reinisch, W, Karlén, P, Schreiber, S, Schall, TJ & Bekker, P 2013, 'A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease', P L o S One, bind 8, nr. 3, e60094. https://doi.org/10.1371/journal.pone.0060094

@article{f28f628f4c724a128509f554f64cf4b2,

title = "A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease",

author = "Satish Keshav and Tom{\'a}{\v s} Va{\v n}{\'a}sek and Yaron Niv and Robert Petryka and Stephanie Howaldt and Mauro Bafutto and Istv{\'a}n R{\'a}cz and David Hetzel and Nielsen, {Ole Haagen} and S{\'e}verine Vermeire and Walter Reinisch and Per Karl{\'e}n and Stefan Schreiber and Schall, {Thomas J} and Pirow Bekker",

year = "2013",

doi = "10.1371/journal.pone.0060094",

language = "English",

volume = "8",

journal = "P L o S One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "3",

}

TY - JOUR

T1 - A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

AU - Keshav, Satish

AU - Vaňásek, Tomáš

AU - Niv, Yaron

AU - Petryka, Robert

AU - Howaldt, Stephanie

AU - Bafutto, Mauro

AU - Rácz, István

AU - Hetzel, David

AU - Nielsen, Ole Haagen

AU - Vermeire, Séverine

AU - Reinisch, Walter

AU - Karlén, Per

AU - Schreiber, Stefan

AU - Schall, Thomas J

AU - Bekker, Pirow

PY - 2013

Y1 - 2013

U2 - 10.1371/journal.pone.0060094

DO - 10.1371/journal.pone.0060094

M3 - Journal article

C2 - 23527300

SN - 1932-6203

VL - 8

JO - P L o S One

JF - P L o S One

IS - 3

M1 - e60094

ER -